Titlebook: Drug Resistance in Leishmania Parasites; Consequences, Molecu Alicia Ponte-Sucre,Emilia Diaz,Maritza Padrón-Niev Book 20131st edition Sprin

incontestable

書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites影響因子(影響力)




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites被引頻次




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites被引頻次學(xué)科排名




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites年度引用




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites年度引用學(xué)科排名




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites讀者反饋




書(shū)目名稱(chēng)Drug Resistance in Leishmania Parasites讀者反饋學(xué)科排名

Flinch

Molecular Evolution and Phylogeny of , e increasingly used intrinsic characters to assign . organisms into different species, they are still heirs of the first classifications based primarily on extrinsic characters. The current classification system, which proposes up to 35 species, is based on multilocus enzyme electrophoresis which is

agenda

The Role of Reservoirs: Canine Leishmaniasisns of dogs in Asia, Europe, North Africa, and South America and is an emergent disease in North America. Domestic dogs (.) are the major hosts for these parasites and the main reservoir hosts for human visceral infection..Recent years have seen important advances on the epidemiology, pathology, and

值得贊賞

Buttress

The Role of the Immune System in Resistance to Infectiontion. The outcome of infection depends on the parasite species as well as host genetic factors and immune competence. In order to develop a successful infection, the . must evade both the innate and adaptive immune responses. Whilst protective immunity has been driven by Th1-type T cell responses, t

妨礙議事

Vaccination as a Control Measureimmune mechanisms for designing vaccines. The following section deals with the first-generation vaccines against cutaneous and visceral leishmaniasis and the candidates for second-generation vaccines, including live vaccines and vaccines based on purified and recombinant . antigens. Thereafter, the

妨礙議事

syring

COWER

Visceral Leishmaniasisnt subset of patients with visceral leishmaniasis were not responding to SbV in the State of Bihar, India. Revised recommendations using tenfold more drug provided a transient reprieve; however, a large proportion of patients in India, and to some extent in Nepal, remained unresponsive to SbV. Besid

thwart

American Tegumentary Leishmaniasispecies, and, thus, there are intraspecific parasitological dissimilarities that may generate different pathologies. Furthermore, in America, . spp. has diverse reservoirs (that may change continuously) and can use various vectors to infect humans and mammals. Antimonials are the drugs of choice for